rs3740904

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_001378964.1(CDON):​c.3294G>A​(p.Thr1098Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.368 in 1,598,876 control chromosomes in the GnomAD database, including 109,930 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.37 ( 10640 hom., cov: 32)
Exomes 𝑓: 0.37 ( 99290 hom. )

Consequence

CDON
NM_001378964.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.325

Publications

22 publications found
Variant links:
Genes affected
CDON (HGNC:17104): (cell adhesion associated, oncogene regulated) This gene encodes a cell surface receptor that is a member of the immunoglobulin superfamily. The encoded protein contains three fibronectin type III domains and five immunoglobulin-like C2-type domains. This protein is a member of a cell-surface receptor complex that mediates cell-cell interactions between muscle precursor cells and positively regulates myogenesis. [provided by RefSeq, Aug 2011]
CDON Gene-Disease associations (from GenCC):
  • holoprosencephaly 11
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Illumina
  • pituitary stalk interruption syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.3).
BP6
Variant 11-125978366-C-T is Benign according to our data. Variant chr11-125978366-C-T is described in ClinVar as Benign. ClinVar VariationId is 260793.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.325 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.419 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDONNM_001378964.1 linkc.3294G>A p.Thr1098Thr synonymous_variant Exon 18 of 20 ENST00000531738.6 NP_001365893.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDONENST00000531738.6 linkc.3294G>A p.Thr1098Thr synonymous_variant Exon 18 of 20 1 NM_001378964.1 ENSP00000432901.2 Q4KMG0-2E9PN78

Frequencies

GnomAD3 genomes
AF:
0.373
AC:
56533
AN:
151750
Hom.:
10624
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.352
Gnomad AMI
AF:
0.304
Gnomad AMR
AF:
0.428
Gnomad ASJ
AF:
0.350
Gnomad EAS
AF:
0.390
Gnomad SAS
AF:
0.405
Gnomad FIN
AF:
0.427
Gnomad MID
AF:
0.415
Gnomad NFE
AF:
0.363
Gnomad OTH
AF:
0.360
GnomAD2 exomes
AF:
0.384
AC:
93281
AN:
243128
AF XY:
0.383
show subpopulations
Gnomad AFR exome
AF:
0.346
Gnomad AMR exome
AF:
0.445
Gnomad ASJ exome
AF:
0.356
Gnomad EAS exome
AF:
0.384
Gnomad FIN exome
AF:
0.420
Gnomad NFE exome
AF:
0.361
Gnomad OTH exome
AF:
0.383
GnomAD4 exome
AF:
0.368
AC:
532225
AN:
1447008
Hom.:
99290
Cov.:
30
AF XY:
0.369
AC XY:
265159
AN XY:
719560
show subpopulations
African (AFR)
AF:
0.354
AC:
11759
AN:
33258
American (AMR)
AF:
0.440
AC:
19355
AN:
44014
Ashkenazi Jewish (ASJ)
AF:
0.354
AC:
9222
AN:
26030
East Asian (EAS)
AF:
0.384
AC:
15186
AN:
39576
South Asian (SAS)
AF:
0.401
AC:
33937
AN:
84622
European-Finnish (FIN)
AF:
0.409
AC:
21722
AN:
53110
Middle Eastern (MID)
AF:
0.351
AC:
2010
AN:
5734
European-Non Finnish (NFE)
AF:
0.360
AC:
396375
AN:
1100754
Other (OTH)
AF:
0.378
AC:
22659
AN:
59910
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
14929
29858
44788
59717
74646
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12668
25336
38004
50672
63340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.373
AC:
56589
AN:
151868
Hom.:
10640
Cov.:
32
AF XY:
0.378
AC XY:
28048
AN XY:
74202
show subpopulations
African (AFR)
AF:
0.352
AC:
14589
AN:
41400
American (AMR)
AF:
0.428
AC:
6526
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.350
AC:
1212
AN:
3460
East Asian (EAS)
AF:
0.389
AC:
2009
AN:
5158
South Asian (SAS)
AF:
0.403
AC:
1938
AN:
4806
European-Finnish (FIN)
AF:
0.427
AC:
4497
AN:
10542
Middle Eastern (MID)
AF:
0.412
AC:
121
AN:
294
European-Non Finnish (NFE)
AF:
0.363
AC:
24658
AN:
67934
Other (OTH)
AF:
0.361
AC:
762
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1840
3680
5519
7359
9199
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
546
1092
1638
2184
2730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.364
Hom.:
31328
Bravo
AF:
0.369
Asia WGS
AF:
0.410
AC:
1425
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Holoprosencephaly 11 Benign:3
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 25, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.30
CADD
Benign
0.72
DANN
Benign
0.66
PhyloP100
-0.33
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=91/9
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3740904; hg19: chr11-125848261; COSMIC: COSV54996106; API